1. Home
  2. NTST vs PHVS Comparison

NTST vs PHVS Comparison

Compare NTST & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSTREIT Corp.

NTST

NetSTREIT Corp.

HOLD

Current Price

$20.26

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Pharvaris N.V.

PHVS

Pharvaris N.V.

HOLD

Current Price

$25.40

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTST
PHVS
Founded
2019
2015
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.8B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
NTST
PHVS
Price
$20.26
$25.40
Analyst Decision
Strong Buy
Buy
Analyst Count
13
10
Target Price
$21.15
$40.70
AVG Volume (30 Days)
1.6M
102.7K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
4.36%
N/A
EPS Growth
150.00
N/A
EPS
0.08
N/A
Revenue
$195,006,000.00
N/A
Revenue This Year
$15.47
N/A
Revenue Next Year
$14.57
N/A
P/E Ratio
$252.38
N/A
Revenue Growth
19.79
N/A
52 Week Low
$14.00
$11.51
52 Week High
$21.30
$29.80

Technical Indicators

Market Signals
Indicator
NTST
PHVS
Relative Strength Index (RSI) 52.65 41.76
Support Level $17.67 $24.25
Resistance Level $21.30 $26.11
Average True Range (ATR) 0.40 1.12
MACD -0.14 -0.19
Stochastic Oscillator 15.79 9.24

Price Performance

Historical Comparison
NTST
PHVS

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: